• Exchange: Helsinki
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

ORNAV:FH

26.6500 EUR 0.2800 1.06%

As of 11:29:59 ET on 07/11/2014.

Snapshot for Orion OYJ (ORNAV)

Open: 26.3100 Day's Range: 26.3100 - 26.7000 Volume: 1,288
Previous Close: 26.3700 52wk Range: 17.4100 - 28.1000 1-Yr Rtn: +49.03%

Stock Chart for ORNAV

No chart data available.
  • ORNAV:FH 26.6500
  • 1D
  • 1M
  • 1Y
26.3700
Interactive ORNAV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ORNAV

Current P/E Ratio (ttm) 18.2534
Estimated P/E(12/2014) 18.5585
Relative P/E vs. HEXP 0.6597
Earnings Per Share (EUR) (ttm) 1.4600
Est. EPS (EUR) (12/2014) 1.4360
Est. PEG Ratio -
Market Cap (M EUR) 3,776.40
Shares Outstanding (M) 41.37
30 Day Average Volume 12,681
Price/Book (mrq) 7.2897
Price/Sale (ttm) 3.7321
Dividend Indicated Gross Yield 4.69%
Cash Dividend (EUR) 1.2500
Dividend Ex-Date 03/26/2014
5 Year Dividend Growth 5.64%
Next Earnings Announcement 07/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ORNAV

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ORNAV

Orion Oyj develops and manufactures pharmaceuticals and diagnostic kits. The Company produces hormone therapies and drugs to treat central nervous system disorders, cardiovascular diseases and urological disorders, and in vitro diagnostic kits used in doctor's offices and small laboratories.

Hannu SyrjaenenChairmanJukka YlppoVice Chairman
Timo LappalainenPresident/CEOJari KarlsonChief Financial Officer
More Company Profile & Key Executives for ORNAV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil